Evaluation of the effect of protective genetic variants on cart success in hiv-1-infected patients: Journal of Biological Regulators and Homeostatic Agents

E.M. Lori, A. Cozzi-Lepri, A. Tavelli, V. Mercurio, S.V. Ibba, S. Lo Caputo, F. Castelli, A. Castagna, A. Gori, G. Marchetti, C. Venditti, M. Clerici, A. D’Arminio Monforte, M. Biasin, Icona Foundation Study Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1553-1559
Number of pages7
JournalJ. Biol. Regul. Homeostatic Agents
Volume34
Issue number4
Publication statusPublished - 2020

Keywords

  • ERAP2
  • HAART
  • HIV-1
  • ICONA
  • Polymorphisms
  • anti human immunodeficiency virus agent
  • CD4 antigen
  • genomic DNA
  • toll like receptor 3
  • adult
  • antiretroviral therapy
  • CD4+ T lymphocyte
  • CD8+ T lymphocyte
  • cohort analysis
  • female
  • gene amplification
  • genetic variability
  • genotype
  • human
  • Human immunodeficiency virus 1 infection
  • infection control
  • Letter
  • major clinical study
  • male
  • population distribution
  • prevalence
  • single nucleotide polymorphism
  • sustained virologic response
  • treatment response
  • virus load
  • CD4 lymphocyte count
  • genetics
  • Human immunodeficiency virus 1
  • Human immunodeficiency virus infection
  • CD4 Lymphocyte Count
  • HIV Infections
  • Humans

Cite this